Real-time enrollment status for this epithelial ovarian cancer clinical trial
Current Status
Recruiting
Checked: October 12, 2026 at 1:44 PM UTC
| NCT Number | NCT07218809 |
| Recruiting Status | Recruiting |
| Condition | Epithelial Ovarian Cancer |
| Phase | PHASE3 |
| Target Enrollment | 1,100 participants |
| Active Locations | 40 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | July 21, 2026 (Jul 21, 2026) |
As of October 12, 2026: Clinical trial NCT07218809 is currently recruiting participants. This phase3 study for epithelial ovarian cancer is actively seeking new participants at 40 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07218809 is actively recruiting participants as of October 12, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07218809 was last updated Jul 21, 2026 (July 21, 2026). HelloStudys verifies this status automatically.